Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication August 6, 2019
- Accepted for publication October 7, 2019
- Published online June 4, 2020.
Article Versions
- previous version (November 1, 2019 - 13:36).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Esther Mena1,
- Maria Liza Lindenberg1,
- Ismail Baris Turkbey1,
- Joanna H. Shih2,
- Stephanie A. Harmon3,
- Ilhan Lim1,
- Frank Lin1,
- Stephen Adler3,
- Philip Eclarinal1,
- Yolanda L. McKinney1,
- Deborah Citrin4,
- William Dahut5,
- Bradford J. Wood6,
- Venkatesh Krishnasamy6,
- Richard Chang6,
- Elliot Levy6,
- Maria Merino7,
- Peter Pinto8,
- Janet F. Eary9 and
- Peter L. Choyke1
- 1Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- 2Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- 3Clinical Research Directorate, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- 4Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- 5Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- 6Center of Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- 7Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- 8Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and
- 9Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- For correspondence or reprints contact: Esther Mena, Molecular Imaging Program, NCI, Building 10, B3B402, Bethesda, MD 20892. E-mail: esther.menagonzalez{at}nih.gov
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Changes in Management After 18F-DCFPyL PSMA PET in Patients Undergoing Postprostatectomy Radiotherapy, with Early Biochemical Response Outcomes
- Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy
- 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study
- 18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
- Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non-Tumor-Related Uptake and Tumor Positivity
- Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
- Positive Predictive Value and Correct Detection Rate of 18F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard